Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × FED × Genitourinary × Clear all

Phase

Phase NA 21 Phase 2 18 Phase 3 6 Phase 2/3 2 Phase 1 2 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

OTHER 339 INDUSTRY 320 NIH 39 OTHER_GOV 3 NETWORK 2 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3 Gastrointestinal 2 Tumor-Agnostic 1 Gynecologic 1 Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1

Interventions

copanlisib 1 avelumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05687721 2025-06-15

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

VA Office of Research and Development

Phase 1/2 Withdrawn

Urinary Bladder Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡